Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 1, 2007
Grant Date -
Mar 17, 2005
app pub date -
Feb 17, 2004
filing date -
Oct 3, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully